Previous Close | 74.50 |
Open | 72.00 |
Bid | 73.00 x 11000 |
Ask | 75.00 x 8000 |
Day's Range | 72.00 - 73.00 |
52 Week Range | 35.00 - 77.00 |
Volume | |
Avg. Volume | 36 |
Market Cap | 1.173B |
Beta (5Y Monthly) | 1.19 |
PE Ratio (TTM) | 108.21 |
EPS (TTM) | 0.67 |
Earnings Date | N/A |
Forward Dividend & Yield | 2.00 (2.76%) |
Ex-Dividend Date | May 28, 2024 |
1y Target Est | N/A |
Ad hoc announcement pursuant to Art. 53 LR Giovanni Di Napoli appointed as new CEO effective from 24 May 2024. Current CEO Alessandro Della Chà to be appointed ...
Dublin, Ireland--(Newsfile Corp. - April 12, 2024) - Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) announces that Medtronic plc (NYSE: MDT), a global leader in healthcare technology, presented at the Genius Summit 2024 the latest advancements in artificial intelligence (AI) for endoscopic care by unveiling ColonPRO™, the latest generation software for the GI Genius™ intelligent endoscopy system ...
Shareholders in Cosmo Pharmaceuticals N.V. ( VTX:COPN ) may be thrilled to learn that the analysts have just delivered...